TABLE OF CONTENTS
|  | | | | Volume 117, Issue 6 (757-911)
Published online 5 September 2017
|  | In this issue
 Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Also new today
 Advance online publication
Digital Edition
| | | | Clinical Studies | Top | | Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer Tudor-Eliade Ciuleanu, Samreen Ahmed, Joo-Hang Kim, Jörg Mezger, Keunchil Park, Michael Thomas, Jihong Chen, Srinivasu Poondru, Jan M VanTornout, Debbie Whitcomb and Fiona Blackhall Br J Cancer 2017 117: 757-766; advance online publication, August 3, 2017; 10.1038/bjc.2017.226 Abstract | Full Text | | | | GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS) J Mora, A Castañeda, S Perez-Jaume, A Lopez-Pousa, E Maradiegue, C Valverde, J Martin-Broto, X Garcia del Muro, O Cruz, J Cruz, J Martinez-Trufero, J Maurel, M A Vaz, E de Alava and C de Torres Br J Cancer 2017 117: 767-774; advance online publication, August 8, 2017; 10.1038/bjc.2017.252 Abstract | Full Text | | | | Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry Paula Jiménez Fonseca, Alberto Carmona-Bayonas, Raquel Hernández, Ana Custodio, Juana Maria Cano, Alejandra Lacalle, Isabel Echavarria, Ismael Macias, Monserrat Mangas, Laura Visa, Elvira Buxo, Felipe Álvarez Manceñido, Antonio Viudez, Carles Pericay, Aitor Azkarate, Avinash Ramchandani, Carlos López, Eva Martinez de Castro, Ana Fernández Montes, Federico Longo, Rodrigo Sánchez Bayona, Maria Luisa Limón, Asun Diaz-Serrano, Alfonso Martin Carnicero, David Arias, Paula Cerdà, Fernando Rivera, Jose Maria Vieitez, Manuel Sánchez Cánovas, M Garrido and J Gallego on behalf of the AGAMENON study group Br J Cancer 2017 117: 775-782; advance online publication, August 1, 2017; 10.1038/bjc.2017.245 Abstract | Full Text | | | | Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway Emily A Burger, Kine Pedersen, Stephen Sy, Ivar Sønbø Kristiansen and Jane J Kim Br J Cancer 2017 117: 783-790; advance online publication, August 3, 2017; 10.1038/bjc.2017.248 Abstract | Full Text | | Translational Therapeutics | Top | | Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform Gilberto S Almeida, Rafal Panek, Albert Hallsworth, Hannah Webber, Efthymia Papaevangelou, Jessica KR Boult, Yann Jamin, Louis Chesler and Simon P Robinson Br J Cancer 2017 117: 791-800; advance online publication, August 8, 2017; 10.1038/bjc.2017.251 Abstract | Full Text | | | | miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment Despina Piatopoulou, Margaritis Avgeris, Antonios Marmarinos, Marieta Xagorari, Margarita Baka, Dimitrios Doganis, Lydia Kossiva, Andreas Scorilas and Dimitrios Gourgiotis Br J Cancer 2017 117: 801-812; advance online publication, August 8, 2017; 10.1038/bjc.2017.256 Abstract | Full Text | | | | Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A Siti Aminah Abdul Rahim, Anne Dirkse, Anais Oudin, Anne Schuster, Jill Bohler, Vanessa Barthelemy, Arnaud Muller, Laurent Vallar, Bassam Janji, Anna Golebiewska and Simone P Niclou Br J Cancer 2017 117: 813-825; advance online publication, August 10, 2017; 10.1038/bjc.2017.263 Abstract | Full Text | | Molecular Diagnostics | Top | | Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers Sergey Klimov, Padmashree CG Rida, Mohammed A Aleskandarany, Andrew R Green, Ian O Ellis, Emiel AM Janssen, Emad A Rakha and Ritu Aneja Br J Cancer 2017 117: 826-834; advance online publication, July 18, 2017; 10.1038/bjc.2017.224 Abstract | Full Text | | | | Active multiple myeloma suppresses and typically eliminates coexisting MGUS John P Campbell, Jennifer L J Heaney, Sankalp Pandya, Zaheer Afzal, Martin Kaiser, Roger Owen, J Anthony Child, Walter Gregory, Gareth J Morgan, Graham H Jackson, Chris M Bunce and Mark T Drayson Br J Cancer 2017 117: 835-839; advance online publication, July 20, 2017; 10.1038/bjc.2017.229 Abstract | Full Text | | | | Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients Ingvild L Tangen, Reidun K Kopperud, Nicole CM Visser, Anne C Staff, Solveig Tingulstad, Janusz Marcickiewicz, Frédéric Amant, Line Bjørge, Johanna MA Pijnenborg, Helga B Salvesen, Henrica MJ Werner, Jone Trovik and Camilla Krakstad Br J Cancer 2017 117: 840-847; advance online publication, July 27, 2017; 10.1038/bjc.2017.235 Abstract | Full Text | | | | Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion Rajat Bhattacharya, Fan Fan, Rui Wang, Xiangcang Ye, Ling Xia, Delphine Boulbes and Lee M Ellis Br J Cancer 2017 117: 848-855; advance online publication, July 25, 2017; 10.1038/bjc.2017.238 Abstract | Full Text | | | | Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis Alhadi Almangush, Ilkka Heikkinen, Antti A Mäkitie, Ricardo D Coletta, Esa Läärä, Ilmo Leivo and Tuula Salo Br J Cancer 2017 117: 856-866; advance online publication, July 27, 2017; 10.1038/bjc.2017.244 Abstract | Full Text | | | | Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma A A Elmusrati, A E Pilborough, S A Khurram and D W Lambert Br J Cancer 2017 117: 867-875; advance online publication, July 25, 2017; 10.1038/bjc.2017.239 Abstract | Full Text | | Genetics & Genomics | Top | | Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma Jen Y Lee, Isaac Garcia-Murillas, Rosalind J Cutts, David Gonzalez De Castro, Lorna Grove, Tara Hurley, Fuqiang Wang, Christopher Nutting, Katie Newbold, Kevin Harrington, Nicholas Turner and Shreerang Bhide Br J Cancer 2017 117: 876-883; advance online publication, August 15, 2017; 10.1038/bjc.2017.258 Abstract | Full Text | | | | GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi M J C Vader, M C Madigan, M Versluis, H M Suleiman, G Gezgin, N A Gruis, J J Out-Luiting, W Bergman, R M Verdijk, M J Jager and P A van der Velden Br J Cancer 2017 117: 884-887; advance online publication, August 15, 2017; 10.1038/bjc.2017.259 Abstract | Full Text | | Epidemiology | Top | | Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries M L Tørring, P Murchie, W Hamilton, P Vedsted, M Esteva, M Lautrup, M Winget and G Rubin Br J Cancer 2017 117: 888-897; advance online publication, August 8, 2017; 10.1038/bjc.2017.236 Abstract | Full Text | | | | Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population Yun Zhu, Peizhong Peter Wang, Guangju Zhai, Bharati Bapat, Sevtap Savas, Jennifer R Woodrow, Ishor Sharma, Yuming Li, Xin Zhou, Ning Yang, Peter T Campbell, Elizabeth Dicks, Patrick S Parfrey and John R Mclaughlin Br J Cancer 2017 117: 898-906; advance online publication, August 1, 2017; 10.1038/bjc.2017.242 Abstract | Full Text | | | | The inflammatory potential of diet and ovarian cancer risk: results from two prospective cohort studies Fred K Tabung, Tianyi Huang, Edward L Giovannucci, Stephanie A Smith-Warner, Shelley S Tworoger and Elizabeth M Poole Br J Cancer 2017 117: 907-911; advance online publication, August 3, 2017; 10.1038/bjc.2017.246 Abstract | Full Text | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment